Eltrombopag in Treating Post‐Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering
Year: 2025
Type: article
Language: en
Topic: Platelet Disorders and Treatments
Authors and affiliations:
raw_author_name: Rawan Al‐Omari
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Ram Vasudevan Nampoothiri
raw_affiliation_strings: Transplantation and Cellular Therapy Program Ottawa Hospital  Ottawa Canada
Transplantation and Cellular Therapy Program, Ottawa Hospital, Ottawa, Canada
raw_author_name: Ali Sakhdari
raw_affiliation_strings: Department of Pathology Princess Margaret Cancer Centre  Toronto Canada
Department of Pathology, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Eshetu G. Atenafu
raw_affiliation_strings: Department of Biostatistics Princess Margaret Cancer Centre  Toronto Canada
Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Caden Chiarello
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Dennis D. Kim
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Arjun Law
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Ivan Pasic
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Igor Novitzky‐Basso
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Auro Viswabandya
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Fotios V. Michelis
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Jonas Mattsson
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
raw_author_name: Rajat Kumar
raw_affiliation_strings: Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre  Toronto Canada
Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada